Save 85% with brand Orgovyx from Europe.
Information about Orgovyx (Relugolix)
Orgovyx (Relugolix) is an oral medication primarily used for the treatment of prostate cancer in adult men. It is a gonadotropin-releasing hormone (GnRH) antagonist that works by lowering the levels of testosterone in the body. By suppressing testosterone production, Orgovyx helps to slow the growth of prostate cancer cells, which are often driven by high levels of this hormone.
Product Highlights
- Orgovyx is used for the treatment of metastatic or advanced prostate cancer. Prostate cancer growth is often dependent on testosterone, and by reducing testosterone levels, Orgovyx helps to control the progression of the disease.
- It is also used as part of the treatment for prostate cancer in cases where the disease has become resistant to other forms of treatment (castration-resistant prostate cancer).
Key Ingredient
Key Benefits of Orgovyx (Relugolix):
- By inhibiting GnRH signaling, Orgovyx rapidly lowers testosterone levels, achieving medical castration in men with advanced prostate cancer.
- Unlike traditional GnRH agonists that are typically administered via injection, Orgovyx is taken as a once-daily oral tablet, which may be more convenient for some patients.
- Testosterone suppression occurs quickly, often within a few days of starting treatment, providing rapid control of prostate cancer growth.
- Compared to some GnRH agonists, which can have an increased risk of cardiovascular issues, Orgovyx has been associated with a potentially lower incidence of cardiac-related side effects.
- Orgovyx is suitable for long-term use in the management of advanced prostate cancer, with regular monitoring to assess effectiveness and side effects.
Direction of Use
- The typical starting dose of Orgovyx is 120 mg once daily for the first 30 days, followed by 40 mg once daily for maintenance after the initial dosing phase.
- Orgovyx should be taken orally, with or without food. It is important to swallow the tablet whole and not to chew, crush, or split it.
- For best results, take the medication at the same time each day. Missing doses or stopping the treatment without medical supervision could lead to a rise in testosterone levels, which may lead to a recurrence of prostate cancer symptoms.
- Orgovyx is typically taken as part of long-term therapy. The exact duration of treatment should be determined by the oncologist based on the patient's condition and response to the drug.
Safety Concerns
- A common symptom due to the reduction in testosterone.
- Some men may feel more tired or lethargic while taking Orgovyx.
- A reduction in sexual desire is a common side effect due to lower testosterone levels.
- Long-term use of testosterone suppression drugs can lead to decreased bone mineral density, increasing the risk of fractures.
- Orgovyx may cause increases in blood sugar, potentially affecting patients with diabetes or increasing the risk of developing diabetes.
- Although Orgovyx has been associated with a lower risk of heart problems compared to some GnRH agonists, there is still a possibility of cardiovascular effects, such as increased blood pressure.
- Liver function tests should be monitored during treatment, as the medication could have effects on the liver in some individuals.
Avoid Orgovyx (Relugolix) If
- Do not use Orgovyx if you are allergic to relugolix or any of the other components of the tablet. Signs of an allergic reaction may include a rash, itching, swelling, or shortness of breath.
- Orgovyx is not intended for use in women and should not be used if pregnant or planning to become pregnant. Testosterone suppression could harm a developing fetus.
- If you have severe liver problems, Orgovyx may not be suitable for you. Liver function should be assessed before starting therapy and monitored during treatment.
- Although Orgovyx is associated with fewer cardiovascular risks than some other treatments, men with severe heart disease or uncontrolled hypertension should use it with caution. Discuss any pre-existing cardiovascular conditions with your doctor before starting treatment.
- Orgovyx can decrease bone mineral density, and it may not be appropriate for men with severe osteoporosis or bone-related disorders unless managed with appropriate bone-strengthening medications.
